Viatris Inc. to Release Third Quarter 2021 Financial Results on Nov. 8, 2021
Viatris Inc. (NASDAQ: VTRS) will release its third quarter 2021 financial results on November 8 before the U.S. market opens. CEO Michael Goettler, President Rajiv Malik, and CFO Sanjeev Narula will host a webcast at 10 a.m. ET on the same day to discuss the results. Investors can access the live webcast via investor.viatris.com or by phone. Viatris, formed in November 2020, operates globally and has a portfolio of over 1,400 approved medicines.
- Scheduled third quarter 2021 financial results release on November 8
- Live webcast discussion with executive team on financial results
- Strong portfolio with over 1,400 approved molecules
- None.
PITTSBURGH, Oct. 13, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its third quarter 2021 financial results on Monday, Nov. 8, before the open of the U.S. financial markets. Chief Executive Officer Michael Goettler, President Rajiv Malik and Chief Financial Officer Sanjeev Narula also will host a webcast at 10 a.m. ET on Nov. 8 to discuss the results.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 866.342.8591 or 203.518.9713 for international callers (Conference ID: VTRSQ321). A replay of the webcast also will be available on the website.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of more than 40,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-inc-to-release-third-quarter-2021-financial-results-on-nov-8-2021-301399098.html
SOURCE Viatris Inc.
FAQ
When will Viatris release its third quarter 2021 financial results?
What time is the Viatris Q3 2021 earnings call?
How can I listen to the Viatris earnings call?
What is the significance of Viatris' upcoming earnings report?
